PureTech (Nasdaq: PRTC, LSE: PRTC) is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.

Biotechnology

PureTech Health

Bharatt Chowrira

David Golod

Allison Mead Talbot

Luba Greenwood

Sven Dethlefs

Robert Lyne

Spencer Ball

Joseph Bolen

Eric Elenko

Donna Gillian-Brown

Dilip Kodira

Anita Terpstra

Aleksandra Filipovic

Chase Oswald

Adam Good

David Carney

The Board and Advisory Team at PureTech Health provides strategic oversight, governance, and expert guidance on scientific and clinical advancements. Comprised of experienced executives and renowned scientists, they help steer the company’s direction, ensure regulatory compliance, audit financial practices, and support the development of innovative therapies for complex diseases.

Board and Advisory Team

Heads and Directors Team

Leadership Team

Board and Advisory Team

About

Team members

Other teams at PureTech Health

Heads and Directors Team

Leadership Team